Polish Studies Newsletter

Articles and interviews

Articles per page:
Sort by:

Promoted

Recently added

15.06.2025

O niedostatkach troski i potrzebie empatii. Rozmowa z Dorotą Danielewicz i Magdaleną Moskal. [NIEPEŁNOSPRAWNOŚĆ I ZAANGAŻOWANIE #1]

Niepełnosprawność i zaangażowanie – pod tym hasłem przewodnim tworzymy serię rozmów z aktywistami i aktywistkami, z pisarkami i pisarzami oraz badaczkami i badaczkami, związanymi na różne sposoby z tematem niepełnosprawności.    Do rozmowy w pierwszym odcinku tej serii zaprosiliśmy autorki książek o doświadczeniu niepełnosprawności i opieki: Dorotę Danielewicz, autorkę Drogi Jana (2020) oraz Magdalenę Moskal, autorkę książki Emil i my. Monolog wielodzietnej matki (2021).  

19.03.2025

From Maladic Narratives to Community. A Meeting with Dr. Iwona Boruszkowska and Maria Świątkowska, MA.

What attitudes do contemporary literary studies take toward maladic narratives? What is the communal and emancipatory aspect of these narratives? How can we view the theory of the "wounded narrator" from today's perspective, 30 years after the publication of Arthur Frank's The Wounded Storyteller (1995)? These and other important questions are answered by the editors of an issue of "Ruch Literacki," titled "Maladic Discourse – Illness as Narrative: Theories and Interpretations" (No. 4/2023). The issue of "Ruch Literacki," which prompted this conversation, is available on the journal's website at: https://journals.pan.pl/rl/150189#tabs. 

19.03.2025

Studying Maladic Narratives: A Meeting with Dr. Joanna Szewczyk and Wiktoria Kulak (MA)

Why is the story so necessary (within) illness? What does the statement that illnesses are political mean? What is maladic discourse and what are its characteristics? And why did Susan Sontag change her stance towards metaphors of illness?

We use cookie files to make the use of our website more convenient for our users. If you do not wish cookie files to be saved on your hard drive, please change the settings of your browser. Read about our cookie policy.